247 related articles for article (PubMed ID: 22283575)
1. Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K; Bilton D
Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhaled dry powder mannitol on mucus and its clearance.
Daviskas E; Rubin BK
Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
[TBL] [Abstract][Full Text] [Related]
3. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
Teper A; Jaques A; Charlton B
J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
[TBL] [Abstract][Full Text] [Related]
4. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
5. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
[TBL] [Abstract][Full Text] [Related]
6. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
Gjoerup J; Hilberg O; Bendstrup E
Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
[TBL] [Abstract][Full Text] [Related]
7. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
8. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
Minasian C; Wallis C; Metcalfe C; Bush A
Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349
[TBL] [Abstract][Full Text] [Related]
9. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
[TBL] [Abstract][Full Text] [Related]
10. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
[TBL] [Abstract][Full Text] [Related]
11. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
Daviskas E; Robinson M; Anderson SD; Bye PT
J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422
[TBL] [Abstract][Full Text] [Related]
12. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies.
Hurt K; Bilton D
Respiration; 2014; 88(6):441-8. PubMed ID: 25472021
[TBL] [Abstract][Full Text] [Related]
13. Inhaled mannitol in cystic fibrosis.
Wills PJ
Expert Opin Investig Drugs; 2007 Jul; 16(7):1121-6. PubMed ID: 17594195
[TBL] [Abstract][Full Text] [Related]
14. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
Prescrire Int; 2014 Apr; 23(148):89-91. PubMed ID: 24860889
[TBL] [Abstract][Full Text] [Related]
15. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
Minasian C; Wallis C; Metcalfe C; Bush A
Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410
[TBL] [Abstract][Full Text] [Related]
16. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
Bilton D; Stanford G
Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
[TBL] [Abstract][Full Text] [Related]
17. Mannitol dry powder for inhalation: in patients with cystic fibrosis.
Burness CB; Keating GM
Drugs; 2012 Jul; 72(10):1411-21. PubMed ID: 22755516
[TBL] [Abstract][Full Text] [Related]
18. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Chan HK; Bautovich G
Am J Respir Crit Care Med; 1999 Jun; 159(6):1843-8. PubMed ID: 10351929
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
Daviskas E; Anderson SD; Eberl S; Young IH
Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
[TBL] [Abstract][Full Text] [Related]
20. Inhaled hyperosmolar agents for bronchiectasis.
Hart A; Sugumar K; Milan SJ; Fowler SJ; Crossingham I
Cochrane Database Syst Rev; 2014 May; 2014(5):CD002996. PubMed ID: 24817558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]